Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSevern Trent Regulatory News (SVT)

Share Price Information for Severn Trent (SVT)

Share Price is delayed by 15 minutes
Get Live Data
2,912.00    8.00 (0.28%)
Bid:
2,908.00
Ask:
2,912.00
Spread: 4.00 (0.138%)
Market Cap: £8.79b
SVT Live PriceLast checked at - London Stock Exchange

Intraday Severn Trent Share Chart

Notification of Board Changes

26 May 2016 07:00

RNS Number : 3300Z
Severn Trent PLC
26 May 2016
 

 

26 May 2016

Severn Trent Plc - Notification of Board Changes

The Board of Severn Trent plc, the UK's leading provider of water and waste water services, today announces the following Board and Board Committee changes.

With effect from the Annual General Meeting ("AGM") of the Company on 20 July 2016 two of our Non-Executive Directors, Martin Lamb and Gordon Fryett will be stepping down from the Board, having served eight years and seven years respectively. Martin is the Senior Independent Non-Executive Director and Gordon is Chair of the Corporate Responsibility Committee. Martin and Gordon will therefore not be submitting themselves for re-appointment at the AGM, but resolutions will be put to the AGM in respect of their successors, Kevin Beeston and Dominique Reiniche, as detailed below.

Kevin Beeston will join the Board as a Non-Executive Director and will become a member of the Audit, Remuneration and Nominations Committees with effect from 1 June 2016. He will succeed Martin as the Senior Independent Director on 20 July 2016. Kevin is Chairman of Taylor Wimpey plc and Equiniti plc and also a Non-Executive Director of The Football Association Premier League Limited. He has previously been Chairman of Serco Group plc, Domestic & General Limited and Partnerships in Care Limited and a Non-Executive Director of IMI plc.

Dominique Reiniche will join the Board as a Non-Executive Director and will become a member of the Corporate Responsibility and Nominations Committees with effect from 20 July 2016. Dominique is Independent Vice Chairman of CHR Hansen Holdings A/S and also a Non-Executive Director of Mondi Plc, Paypal (Europe) and AXA SA. After holding senior roles with Procter & Gamble and Kraft-Jacobs Suchard, she has previously been President - Western Europe of Coca-Cola Enterprises, President - Europe and Chairman - Europe of Coca-Cola Company, a Non-Executive Director of Peugeot-Citroen SA and Vice Chairman of FoodDrinkEurope.

Dr. Angela Strank will succeed Gordon as Chair of the Corporate Responsibility Committee on 20 July 2016.

Andrew Duff, Chairman said:

"I would like to thank both Martin and Gordon for their extremely valuable contribution and commitment to the Board during their tenure. I am delighted that Kevin and Dominique have agreed to join the Board as Non-Executive Directors. Their wide ranging experience will be a complementary addition to the Board's existing skill set."

The Company confirms that there is no information about Kevin Beeston or Dominique Reiniche requiring disclosure under paragraph 9.6.13 (1) to (6) of the Listing Rules of the UK Listing Authority.

 

For further information please contact:

 

Ruban Chandran, Head of Investor Relations:

- 07957 166 615

- ruban.chandran@severntrent.co.uk

 

David Lloyd-Seed / Jonathan Sibun, Tulchan Communications:

- 0207 353 4200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADELFLQEFBBBV
Date   Source Headline
4th Feb 20257:00 amRNSSevern Trent Plc – Board Changes
3rd Feb 202511:01 amRNSTotal Voting Rights
24th Jan 20251:26 pmRNSPublication of Supplementary Prospectus
24th Jan 20257:00 amRNSST Plc Trading Update and Final Determination
21st Jan 20254:17 pmRNSDirector/PDMR Shareholding
17th Jan 202511:35 amRNSDirector/PDMR Shareholding
2nd Jan 20259:41 amRNSTotal Voting Rights
19th Dec 202410:23 amRNSSevern Trent Water PR24 Final Determination
2nd Dec 202412:20 pmRNSTotal Voting Rights
28th Nov 20247:00 amRNSAdditional Listing
20th Nov 20247:00 amRNSInterim results for the six months to 30 Sept 2024
1st Nov 202412:28 pmRNSBlock listing Interim Review
1st Nov 202412:17 pmRNSTotal Voting Rights
21st Oct 20243:23 pmRNSSevern Trent Plc - Holding(s) in Company
18th Oct 20242:03 pmRNSDirector/PDMR Shareholding
1st Oct 202412:56 pmRNSSevern Trent Plc - Holding(s) in Company
1st Oct 202412:41 pmRNSTotal Voting Rights
26th Sep 202410:42 amRNSSevern Trent Plc - Holding(s) in Company
13th Sep 202410:40 amRNSDirector/PDMR Shareholding
6th Sep 20243:13 pmRNSSevern Trent Plc - Holding(s) in Company
6th Sep 202411:54 amRNSSevern Trent Plc - Holding(s) in Company
2nd Sep 202410:28 amRNSTotal Voting Rights
13th Aug 20241:32 pmRNSHolding(s) in Company
8th Aug 20244:15 pmRNSDirector/PDMR Shareholding
1st Aug 20242:52 pmRNSTotal Voting Rights
29th Jul 20243:46 pmRNSPublication of Final Terms
29th Jul 20242:40 pmRNSDirector/PDMR Shareholding
23rd Jul 20243:51 pmRNSHolding(s) in Company
23rd Jul 20243:42 pmRNSHolding(s) in Company
23rd Jul 20247:15 amRNSST Plc confirms fifth year of 4-star EPA status
22nd Jul 202411:24 amRNSPublication of a Prospectus
19th Jul 20245:30 pmRNSHolding(s) in Company
16th Jul 20247:13 amRNSWastewater Treatment Information Request
11th Jul 20242:22 pmRNSHolding(s) in Company
11th Jul 202411:48 amRNSResult of AGM
11th Jul 202411:00 amRNSPR24 Business Plan rated ‘Outstanding’
11th Jul 20247:00 amRNSSevern Trent Plc Trading Statement
3rd Jul 20243:58 pmRNSDirector/PDMR Shareholding
1st Jul 20244:17 pmRNSTotal Voting Rights
12th Jun 20245:03 pmRNSDirector/PDMR Shareholding
11th Jun 20245:52 pmRNSDirector/PDMR Shareholding
11th Jun 20247:00 amRNSAnnual Report and Notice of AGM
3rd Jun 202411:53 amRNSHolding(s) in Company
3rd Jun 202411:36 amRNSTotal Voting Rights
29th May 20243:15 pmRNSHolding(s) in Company
22nd May 202412:04 pmRNSPublication of Suppl.Prospcts
22nd May 20247:00 amRNSAnnual Results for the year ended 31 March 2024
10th May 20244:05 pmRNSHolding(s) in Company
8th May 202412:55 pmRNSSevern Trent Plc Directorate Change
3rd May 20243:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.